Intermolecular (IMI) Tops Q1 EPS by 3c

Intermolecular (NASDAQ: IMI) reported Q1 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $14.6 million.

GUIDANCE:

Intermolecular sees Q2 2016 EPS of ($0.07)-($0.05), versus the consensus of ($0.01). Intermolecular sees Q2 2016 revenue of $12.0-12.5 million, versus the consensus of $16.0 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c